ALKERMES | ALKS - Market Capitalization

Stock Price
37.48
Daily Change
-0.88 -2.29%
Monthly
11.00%
Yearly
19.29%
Q2 Forecast
33.96

ALKERMES reported $6.21B in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 364.22B 20.46B May/2026
Acadia Pharmaceuticals USD 3.57B 221M May/2026
ALKERMES USD 5.66B 217M May/2026
Amgen USD 189.89B 13.64B Mar/2026
Biogen USD 26.9B 1.09B Mar/2026
BioMarin Pharmaceutical USD 10.18B 683M May/2026
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Coherus Biosciences USD 172M 19M Dec/2025
Eli Lilly USD 869.02B 146.97B Mar/2026
Gilead Sciences USD 167.39B 5.6B May/2026
Heron Therapeutics USD 238M 7M Dec/2025
Ionis Pharmaceuticals USD 12.46B 356M Mar/2026
J&J USD 579.15B 78.91B Mar/2026
Malin Corporation EUR 142.92M 19.65M Feb/2026
Merck USD 297.1B 35.84B Mar/2026
Nektar Therapeutics USD 15.62B 14.76B May/2026
Neurocrine Biosciences USD 15.15B 1.9B May/2026
Otsuka Holdings JPY 5.98T 1.16T Mar/2026
Ovoca Bio EUR 6.12M 4.93M Apr/2026
Pfizer USD 147.4B 6.42B May/2026
Regeneron Pharmaceuticals USD 81.68B 560M Mar/2026
Vertex Pharmaceuticals USD 113.58B 1000K May/2026